Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,064 | 13,153 | 20,611 | 28,415 | 21,136 |
| Marketable Securities | 61,458 | 56,482 | 4,992 | 9,932 | 21,860 |
| Other current assets | 4,623 | 4,733 | 3,221 | 3,742 | 2,925 |
| TOTAL | $160,145 | $74,368 | $28,824 | $42,089 | $45,921 |
| Non-Current Assets | |||||
| PPE Net | 217 | 252 | 269 | 285 | 346 |
| Investments And Advances | 52,037 | 62,773 | 20,908 | 20,908 | 20,908 |
| Other Non-Current Assets | 13,229 | 13,541 | 13,847 | 14,146 | 14,479 |
| TOTAL | $65,483 | $76,566 | $35,024 | $35,339 | $35,733 |
| Total Assets | $225,628 | $150,934 | $63,848 | $77,428 | $81,654 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,876 | 1,956 | 1,710 | 3,950 | 1,950 |
| Accrued Expenses | 5,413 | 4,899 | 2,959 | 2,872 | 5,997 |
| TOTAL | $15,748 | $8,288 | $6,796 | $8,924 | $9,307 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 718 | 718 | N/A |
| TOTAL | $11,611 | $11,986 | $12,354 | $12,715 | $13,070 |
| Total Liabilities | $27,359 | $20,274 | $19,150 | $21,639 | $22,377 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 186,640 | 131,875 | 71,212 | 71,110 | 71,110 |
| Common Shares | 167 | 130 | 71 | 71 | 71 |
| Retained earnings | -338,701 | -321,713 | -331,376 | -319,218 | -314,533 |
| Other shareholders' equity | -422 | -202 | -126 | -69 | -48 |
| TOTAL | $198,269 | $130,660 | $44,698 | $55,789 | $59,276 |
| Total Liabilities And Equity | $225,628 | $150,934 | $63,848 | $77,428 | $81,653 |